Stephen shares his views on the exuberant reaction of markets around the world to Pfizer's announcement of a vaccine with 90% effectiveness.
He also gives his views on the risks to watch out for in markets and highlights potential opportunities that are not the usual suspects, like the SGX . . .
Please Login to read all contents for free.